
Research led by CUHK identifies high-risk adults and develops a Chinese-specific risk model to curb rising young-onset cases
Diabetes poses a mounting public-health challenge in Hong Kong, with over 700,000 residents living with the condition and more than 570 deaths recorded in 2023 alone.
Health authorities and researchers alike emphasise that lifestyle changes, early diagnosis and effective management remain pivotal to preventing the serious complications associated with the disease.
In a major prevention drive, the Faculty of Medicine at the Chinese University of Hong Kong (CUHK) has launched a screening scheme targeting 9,000 adults aged under 44 who have at least one identifiable risk factor, such as obesity, family history of diabetes or inadequate physical activity.
As of early November, more than 3,300 participants have been tested and about 45 % of them flagged as high-risk.
The initiative is timed to address the growing prevalence of young-onset type 2 diabetes, which research shows carries a higher burden of complications and an elevated risk of cardiovascular and kidney disease.
Complementing the screening programme, CUHK scientists in collaboration with the University of Oxford have developed the first Chinese-tailored predictive tool for diabetes-related complications.
The model—based on data covering over 21,000 diabetes patients and validated against a cohort of 170,000—can evaluate an individual’s lifetime risk of developing ten major complications including stroke, end-stage kidney disease and cancer.
The tool is designed to help doctors personalise treatment plans and guide cost-effective resource allocation by predicting outcomes in a way that reflects population-specific risk profiles.
Research conducted by CUHK has also quantified the substantial economic and productivity losses associated with diabetic disease in Hong Kong.
A modelling study estimated that working-age adults with type 2 diabetes face productivity-adjusted life-year (PALY) losses of 17 % for men and 28 % for women over their working lifetimes, translating into a combined gross-domestic-product loss of approximately HK$232 billion.
The impact was found to be especially severe among younger patients.
To bolster efforts, the Government launched a three-year pilot scheme in 2023 that subsidises private-sector screening and treatment for diabetes.
Officials say that alongside medical interventions, public-health messaging must reinforce the role of balanced diet, regular exercise and weight control in delaying or preventing onset of the condition.
With World Diabetes Day on November 14 flagged as a critical reminder, experts urge the community not to ignore early warning signs of the disease.
If the city is to bend the curve of its diabetes epidemic, researchers argue that combining targeted screening, predictive analytics and lifestyle-based prevention constitutes the most promising approach.
Health authorities and researchers alike emphasise that lifestyle changes, early diagnosis and effective management remain pivotal to preventing the serious complications associated with the disease.
In a major prevention drive, the Faculty of Medicine at the Chinese University of Hong Kong (CUHK) has launched a screening scheme targeting 9,000 adults aged under 44 who have at least one identifiable risk factor, such as obesity, family history of diabetes or inadequate physical activity.
As of early November, more than 3,300 participants have been tested and about 45 % of them flagged as high-risk.
The initiative is timed to address the growing prevalence of young-onset type 2 diabetes, which research shows carries a higher burden of complications and an elevated risk of cardiovascular and kidney disease.
Complementing the screening programme, CUHK scientists in collaboration with the University of Oxford have developed the first Chinese-tailored predictive tool for diabetes-related complications.
The model—based on data covering over 21,000 diabetes patients and validated against a cohort of 170,000—can evaluate an individual’s lifetime risk of developing ten major complications including stroke, end-stage kidney disease and cancer.
The tool is designed to help doctors personalise treatment plans and guide cost-effective resource allocation by predicting outcomes in a way that reflects population-specific risk profiles.
Research conducted by CUHK has also quantified the substantial economic and productivity losses associated with diabetic disease in Hong Kong.
A modelling study estimated that working-age adults with type 2 diabetes face productivity-adjusted life-year (PALY) losses of 17 % for men and 28 % for women over their working lifetimes, translating into a combined gross-domestic-product loss of approximately HK$232 billion.
The impact was found to be especially severe among younger patients.
To bolster efforts, the Government launched a three-year pilot scheme in 2023 that subsidises private-sector screening and treatment for diabetes.
Officials say that alongside medical interventions, public-health messaging must reinforce the role of balanced diet, regular exercise and weight control in delaying or preventing onset of the condition.
With World Diabetes Day on November 14 flagged as a critical reminder, experts urge the community not to ignore early warning signs of the disease.
If the city is to bend the curve of its diabetes epidemic, researchers argue that combining targeted screening, predictive analytics and lifestyle-based prevention constitutes the most promising approach.







































